Effectiveness and tolerability of twice daily dosing of deferasirox in unresponsive and intolerant transfusion-dependent beta-thalassemia patients: A narrative review

Chronic iron overload in beta-thalassemia patients after continuous blood transfusions has caused notable morbidity and mortality in these patients. The once-a-day oral iron chelator, deferasirox has established efficacy and bearable safety in adults and pediatric thalassemia patients. It is now ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu, Tirin, Panachiyil, George Mathew, Sebastian, Juny, Ravi, Mandyam Dhati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Educational Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092177/
https://www.ncbi.nlm.nih.gov/pubmed/33666193
http://dx.doi.org/10.4103/ijp.IJP_333_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092177/
https://www.ncbi.nlm.nih.gov/pubmed/33666193
http://dx.doi.org/10.4103/ijp.IJP_333_19

Ejemplares similares